These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10691912)

  • 1. Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
    Klemetti P; Björses P; Tuomi T; Perheentupa J; Partanen J; Rautonen N; Hinkkanen A; Ilonen J; Vaarala O
    Clin Exp Immunol; 2000 Mar; 119(3):419-25. PubMed ID: 10691912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the humoral immune response to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and/or type 1 diabetes.
    Ronkainen MS; Härkönen T; Perheentupa J; Knip M
    Eur J Endocrinol; 2005 Dec; 153(6):901-6. PubMed ID: 16322397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
    Gylling M; Tuomi T; Björses P; Kontiainen S; Partanen J; Christie MR; Knip M; Perheentupa J; Miettinen A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4434-40. PubMed ID: 11134089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II.
    Seissler J; Bieg S; Yassin N; Mauch L; Northemann W; Boehm BO; Scherbaum WA
    Autoimmunity; 1994; 19(4):231-8. PubMed ID: 7578849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED.
    Meloni A; Corda G; Saba L; Ferri GL; Mariotti S; Cocco C
    J Clin Endocrinol Metab; 2019 Jan; 104(1):150-162. PubMed ID: 30339230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between T-cell responses to glutamate decarboxylase and coxsackievirus B4 in patients with insulin-dependent diabetes mellitus.
    Klemetti P; Hyöty H; Roivainen M; Ilonen J; Savola K; Knip M; Akerblom HK; Vaarala O
    J Clin Virol; 1999 Oct; 14(2):95-105. PubMed ID: 10588452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
    Björk E; Velloso LA; Kämpe O; Karlsson FA
    Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
    Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
    Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients.
    Serjeantson SW; Court J; Mackay IR; Matheson B; Rowley MJ; Tuomi T; Wilson JD; Zimmet P
    Hum Immunol; 1993 Oct; 38(2):97-104. PubMed ID: 8106272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
    Perniola R; Falorni A; Clemente MG; Forini F; Accogli E; Lobreglio G
    Eur J Endocrinol; 2000 Oct; 143(4):497-503. PubMed ID: 11022196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with beta-selective GAD-specific islet cell antibodies.
    Wagner R; McNally JM; Bonifacio E; Genovese S; Foulis A; McGill M; Christie MR; Betterle C; Bosi E; Bottazzo GF
    Diabetes; 1994 Jul; 43(7):851-6. PubMed ID: 7912208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
    De Aizpurua HJ; Wilson YM; Harrison LC
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
    Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
    Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.
    Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM
    Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.